Chemomab Therapeutics Ltd. (CMMB) stock
CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.53+0.13 (+9.29%)
Close on Nov 13, 2026Market cap $11.00MP/E 1.1Yield –
Chemomab Therapeutics cash
Cash and short-term investments held at the end of each period.
Chemomab Therapeutics's cash was $6.70M at Jun 30, 2026. For fiscal 2025 it was $10.40M, down 27.3% from the year before. Over ten years it grew 16.8% a year on average. The highest annual figure on record is $15.24M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.40M | -27.3% |
| FY2024 | Dec 31, 2024 | $14.30M | +52.6% |
| FY2023 | Dec 31, 2023 | $9.37M | -31.1% |
| FY2022 | Dec 31, 2022 | $13.60M | -10.8% |
| FY2021 | Dec 31, 2021 | $15.24M | +30.0% |
| FY2020 | Dec 31, 2020 | $11.73M | -4.5% |
| FY2019 | Dec 31, 2019 | $12.28M | +60.8% |
| FY2018 | Dec 31, 2018 | $7.64M | +425.2% |
| FY2017 | Dec 31, 2017 | $1.45M | -68.1% |
| FY2016 | Dec 31, 2016 | $4.56M | +107.2% |
| FY2015 | Dec 31, 2015 | $2.20M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.70M | +31.1% |
| Q4 FY2025 | Dec 31, 2025 | $10.40M | +11.0% |
| Q2 FY2025 | Jun 30, 2025 | $9.50M | -9.1% |
| Q4 FY2024 | Dec 31, 2024 | $14.30M | -31.1% |
| Q2 FY2024 | Jun 30, 2024 | $5.11M | -62.4% |
| Q4 FY2023 | Dec 31, 2023 | $9.37M | -12.8% |
| Q2 FY2023 | Jun 30, 2023 | $10.46M | +5.0% |
| Q1 FY2023 | Mar 31, 2023 | $20.77M | +49.3% |
| Q4 FY2022 | Dec 31, 2022 | $13.60M | -10.8% |
| Q3 FY2022 | Sep 30, 2022 | $10.74M | -71.6% |
| Q2 FY2022 | Jun 30, 2022 | $9.96M | -78.1% |
| Q1 FY2022 | Mar 31, 2022 | $13.91M | -76.1% |
| Q4 FY2021 | Dec 31, 2021 | $15.24M | +30.0% |
| Q3 FY2021 | Sep 30, 2021 | $37.80M | +197.0% |
| Q2 FY2021 | Jun 30, 2021 | $45.45M | +247.4% |
| Q1 FY2021 | Mar 31, 2021 | $58.23M | +437.4% |
| Q4 FY2020 | Dec 31, 2020 | $11.73M | -4.5% |
| Q3 FY2020 | Sep 30, 2020 | $12.73M | -45.2% |
| Q2 FY2020 | Jun 30, 2020 | $13.08M | -51.6% |
| Q1 FY2020 | Mar 31, 2020 | $10.84M | -66.3% |
| Q4 FY2019 | Dec 31, 2019 | $12.28M | +60.8% |
| Q3 FY2019 | Sep 30, 2019 | $23.24M | +1498.4% |
| Q2 FY2019 | Jun 30, 2019 | $27.00M | +491.7% |
| Q1 FY2019 | Mar 31, 2019 | $32.13M | +1358.6% |
| Q4 FY2018 | Dec 31, 2018 | $7.64M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.45M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.56M | – |
| Q4 FY2015 | Dec 31, 2015 | $2.20M | – |
See a number that looks wrong?